A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience


Cekdemir D., Guvenc S., Ozdemirkiran F., Eser A., Topts T., Ozkocaman V., ...More

TURKISH JOURNAL OF HEMATOLOGY, vol.36, no.4, pp.230-237, 2019 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 36 Issue: 4
  • Publication Date: 2019
  • Doi Number: 10.4274/tjh.galenos.2019.2018.0307
  • Journal Name: TURKISH JOURNAL OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.230-237
  • Süleyman Demirel University Affiliated: Yes

Abstract

Objective: The aim of the present study was to evaluate the efficacy and safety of eltrombopag, an oral thrombopoietin receptor agonist, in patients with chronic immune thrombocytopenia (ITP).